Dianlong Zhang
Dalian, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Clinical practice guidelines for prognosis and follow-up of early-stage breast cancer patients: Chinese Society of Breast Surgery (CSBrS) practice guidelines (2026 edition) Chinese Society of Breast Surgery, Chinese Society of Surgery, Chinese Medical Association.
Journal: Translational breast cancer research : a journal focusing on translational research in breast cancer
Published: October 22, 2025
Overexpression of CSRP1 Suppresses Cell Viability and Enhances the Anti-Cancer Effects of Anti-PD-L1 Therapy in Renal Cell Carcinoma.
Journal: Frontiers in bioscience (Landmark edition)
Published: September 02, 2025
An exploration of the optimal combination chemotherapy regimen based on neoadjuvant therapy containing pyrotinib for HER2-positive breast cancer: A multicenter real-world study.
Journal: Translational oncology
Published: August 12, 2024
Endocrine therapy of short duration prevents local and contralateral recurrence of ductal carcinoma in situ of the breast: A multicenter retrospective cohort study in China.
Journal: Chinese medical journal
Published: July 08, 2023
A pan-cancer analysis of ring finger protein 135 and its relationship to triple-negative breast cancer proliferation and metastasis.
Journal: Aging
Published: August 25, 2022
A multicentre single arm phase 2 trial of neoadjuvant pyrotinib and letrozole plus dalpiciclib for triple-positive breast cancer.
Journal: Nature communications
Published: July 27, 2022
A Novel Combined Nomogram Model for Predicting the Pathological Complete Response to Neoadjuvant Chemotherapy in Invasive Breast Carcinoma of No Specific Type: Real-World Study.
Journal: Frontiers in oncology
Published: April 09, 2022
Last Updated: 09/26/2026